Utilization of Non-Drug-Eluting Devices for Inpatient Percutaneous Coronary Intervention in the United States
Recommended Citation
Sedhom R, Cortese B, Khedr M, Bharadwaj A, Brilakis ES, Pershad A, Basir MB, Alaswad K, Yeh RW, and Megaly M. Utilization of Non-Drug-Eluting Devices for Inpatient Percutaneous Coronary Intervention in the United States. Am J Cardiol 2023; 186:209-215.
Document Type
Article
Publication Date
1-1-2023
Publication Title
The American journal of cardiology
Abstract
There is a paucity of data on the contemporary use of non-drug-eluting devices (balloon angioplasty or bare-metal stents) in contemporary percutaneous coronary intervention (PCI) in the United States. We utilized the Nationwide Readmissions Database to identify patients hospitalized to undergo PCI with non-drug-eluting devices from 2016 to 2019. The main outcome of interest was the trends in utilization over the study years. Among 1,870,262 PCI procedures, 127,810 (6.8%) were performed with non-drug-eluting devices; 72% of these were in the setting of acute myocardial infarction (MI). The use of non-drug-eluting devices decreased throughout the study period from 12.9% of all PCI in the first quarter of 2016 to 3.4% in the last quarter of 2019 (p
Medical Subject Headings
Humans; United States; Percutaneous Coronary Intervention; Drug-Eluting Stents; Inpatients; Treatment Outcome; Angioplasty, Balloon, Coronary; Myocardial Infarction; Stents; Risk Factors
PubMed ID
36328830
Volume
186
First Page
209
Last Page
215
